Clinical Trial

SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer

Name: SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer — clinical trial record (NCT06476093)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of SRT combined with anlotinib in the treatment of limited brain metastases from non-small cell lung cancer.

Trial Details

NCT Number	NCT06476093
Lead Sponsor	The First People's Hospital of Lianyungang
Conditions	Non-Small-Cell Lung Cancer, Brain Metastases
Enrollment	46 participants
Start Date	2024-07-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2024-06-26